France· FR:62330898
EXACYL 0,5 g/5 ml I.V., solution injectable
A medicinal product containing tranexamique (acide), registered in France by CHEPLAPHARM ARZNEIMITTEL (ALLEMAGNE), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- TRANEXAMIQUE (ACIDE)
- Manufacturer
- CHEPLAPHARM ARZNEIMITTEL (ALLEMAGNE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009311576185 ampoule(s) en verre de 5 mlEUR 7.39
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tranexamique (acide) in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsTranexaminezuur Accord 100 mg/ml oplossing voor injectieAccord Healthcare B.V.
- United KingdomCyklo-f Heavy Period Relief 500mg tabletsThe Boots Company Plc
- United StatesCyklokapronPfizer Laboratories Div Pfizer Inc
- CzechiaEXACYLCHEPLAPHARM Arzneimittel GmbH, Greifswald
- SwedenCyklo-f 500 mg Filmdragerad tablettViatris AB
- PolandDeporiumAdamed Pharma S.A.
- SwitzerlandCyklokapron
- BelgiumCyklokapron 100 mg/mlPfizer
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Cyklokapron, Tranexamsäure Baxter
- Belgium · Acide Tranexamique Kabi, Cyklokapron
- Bulgaria · Медокапрон, Т-Капрон
- Cyprus · Azeptil, Medsamic
- Czechia · Exacyl, Tranexamic Acid Accord
- Germany · Cyklokapron, Cyklokapron-Injektionslösung
- Denmark · Cyklokapron, Cyklonova
- Estonia · Cyklokapron, Medsamic
- Spain · Ácido Tranexámico Baxter, Ácido Tranexámico Viatris
- Finland · Caprilon, Cyklokapron
- United Kingdom (Northern Ireland) · Cyklo-F, Cyklokapron
- Greece · Tranexamic Acid /Kabi, Tranexamic Acid Baxter
- Croatia · Medsamic, Trenolk
- Hungary · Exacyl, Nimra
- Ireland · Cyklokapron, Tranexamic Acid Accord Healthcare Ireland
- Iceland · Cyklokapron, Tranexamsyre Pfizer
- Italy · Acido Tranexamico Adamed, Acido Tranexamico Aurobindo
- Lithuania · Haixa, Tranexamic Acid Baxter
- Luxembourg · Exacyl, Tranexamsäure Dr. Eberth
- Latvia · Cyklokapron, Haixa
- Malta · Azeptil, Medsamic
- Netherlands · Cyklokapron, Nexag
- Norway · Cyklokapron, Pilexam
- Poland · Deporium, Deporium Comfort
- Portugal · Ácido Tranexâmico A.Forall, Ácido Tranexâmico Accord
- Romania · Acid Tranexamic Kabi, Medsamic
- Sweden · Cyklo-F, Cyklokapron
- Slovenia · Medsamic, Trenolk
- Slovakia · Medsamic, Tranexamic Acid Kabi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f99bf625-9e67-4c4f-a167-8a23243e1626 GET /v1/drugs/f99bf625-9e67-4c4f-a167-8a23243e1626?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "62330898",
"date_amm": "1987-04-22",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "TRANEXAMIQUE (ACIDE)",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about tranexamique (acide).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.